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Endothelial derived hyperpolarizing factor (EDHF), together with endothelial derived NO and 
prostacyclin represent the major endogenous vasodilator hormone pathways (Coleman et al, 
2004). Since the chemical nature of EDHF is uncertain, many studies have relied on 
pharmacological tools. Often EDHF described as the endothelial dependent dilation which is 
resistant to a combination of drugs that inhibit NO synthase (usually L-NAME) and cyclo-
oxygenase (usually indomethacin) but abolished by those that block large and small Ca2+-
activated K+ channels (BKCa and SKCa; with charybdotoxin plus apamin respectively). This 
approach relies on each of these drugs being selective for endothelial dependent responses. In the 
current study we have taken a different approach to most and performed experiments where 
inhibitors were added to endothelium denuded vessels after dilators induced stable vasodilatation.  
Male Wistar rats (200 ± 15.4g) were killed by lethal exposure to CO2. Second order mesenteric 
arteries were mounted in isometric wire myographs and vasomotor responses recorded as 
described previously (Harrington and Mitchell, 2004). In some experiments vessels were 
contracted with EC80 concentration of U46619, dilation was then induced by the addition of 3x10-
6M acetylcholine or 3x10-6M SNP. When either L-NAME (10-4M) or charybdotoxin (10-7M) plus 
apamin (5x10-7M) were added after acetylcholine the vasodilatation was immediately and 
completely reversed (Figure A and B respectively). In other experiments, endothelium 
independent vasodilation induced by SNP, were also reversed by charybdotoxin plus apamin, but 
not L-NAME. 
 
 
 
 
 
 
 
 
 
 
Figure A. Example trace of an artery re-contracting following the addition of L-NAME in 
pre-contracted arteries dilated with acetylcholine. Bar Graphs show re-contraction of 
arteries in response to L-NAME or charybdotoxin plus apamin (C+A) in arteries with 
endothelium, dilated with acetylcholine (Figure B) or without endothelium dilated with 
SNP (Figure C). 
 
This data demonstrates that charybdotoxin and apamin have pharmacological effects 
independent of the endothelium, at the level of smooth muscle cell function. These 
observations suggest results obtained with these drugs in relation to EDHF studies, 
should be treated with caution. 
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